Volition logo logo
  • Investors
Contact UsContact Us
Our Technology
  • Nu.Q® Technology

    Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.

    • Our Tests
    • Human Health
    • Nu.Q® NETs

      Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.

    • Nu.Q® Discover

      Buy our Nu.Q® Discover H3.1 Research Use Only Assay

    • Animal Health
    • Nu.Q® Vet Cancer Test

      Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.

    • Our Service
    • Nu.Q® Discover

      Nu.Q® Discover gives you access to a range of assays, built on our proprietary Nucleosomics™ platform, for rapid epigenetic profiling in disease model development, preclinical testing and clinical studies.

    • Our Pipeline Development
    • Nu.Q® Cancer

      We are developing a range of blood-based assays with potential applications beyond cancer detection.

    • Capture-PCR™

      We have developed Capture-PCR™, a novel method for liquid biopsy enabling rapid, cost-effective cancer detection in a routine blood test.

Human Health
  • Cancer
  • Sepsis
Nu.Q® Products
  • Nu.Q® NETs

    Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.

  • Nu.Q® Discover

    Buy our Nu.Q® Discover H3.1 Research Use Only Assay

  • Nu.Q® Vet

    Nu.Q® Vet Cancer Test is an affordable, accessible blood test to detect cancer in dogs.

Resources
  • Press Releases

    Latest news on Volition and our products.

  • Scientific Resources

    Human Health resources for educational and research purposes.

  • Veterinary Resources

    Animal Health resources for educational and research purposes.

  • Toolkit & Downloads

    Our library for images and educational downloads.

View all resources
About
  • Our Company

    Volition means to have determination and a purpose.

  • Our Team

    Get to know our team of experts behind our research and products.

  • Careers

    We’re always looking for talented individuals to join our mission.

  • Our Technology
    • Nu.Q® Technology

      Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.

      • Our Tests
      • Human Health
      • Nu.Q® NETs

        Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.

      • Nu.Q® Discover

        Buy our Nu.Q® Discover H3.1 Research Use Only Assay

      • Animal Health
      • Nu.Q® Vet Cancer Test

        Nu.Q® Vet Cancer Test is an affordable, accessible blood test that detects cancer in dogs.

      • Our Service
      • Nu.Q® Discover

        Nu.Q® Discover gives you access to a range of assays, built on our proprietary Nucleosomics™ platform, for rapid epigenetic profiling in disease model development, preclinical testing and clinical studies.

      • Our Pipeline Development
      • Nu.Q® Cancer

        We are developing a range of blood-based assays with potential applications beyond cancer detection.

      • Capture-PCR™

        We have developed Capture-PCR™, a novel method for liquid biopsy enabling rapid, cost-effective cancer detection in a routine blood test.

  • Human Health
    • Cancer
    • Sepsis
  • Nu.Q® Products
    • Nu.Q® NETs

      Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.

    • Nu.Q® Discover

      Buy our Nu.Q® Discover H3.1 Research Use Only Assay

    • Nu.Q® Vet

      Nu.Q® Vet Cancer Test is an affordable, accessible blood test to detect cancer in dogs.

  • Resources
    • Press Releases

      Latest news on Volition and our products.

    • Scientific Resources

      Human Health resources for educational and research purposes.

    • Veterinary Resources

      Animal Health resources for educational and research purposes.

    • Toolkit & Downloads

      Our library for images and educational downloads.

    View all resources
  • About
    • Our Company

      Volition means to have determination and a purpose.

    • Our Team

      Get to know our team of experts behind our research and products.

    • Careers

      We’re always looking for talented individuals to join our mission.

  • Investors
Larger beagle image

London Vet Show 2023: Volition Veterinary Highlights.

Blog
Volition 230619

Veterinary Cancer Society 2022 Annual Conference

Events
Volition_Nucleosome_Illustration_Cut_Out

Genomeweb to Host Volition Webinar on EZH2 Inhibitors.

Events
Women in science day 2022 crop

Celebrating International Day of Women and Girls in Science.

Blog
volition-veterinarians-1

Volition to Host Second Genomeweb Webinar.

Blog
Untitled design

Volition presents at EuroMedLab 2022

Events

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases

"*" indicates required fields

Receive product updates for:
Name*
Consent*
volition-nets-4

Volition Hosts Genomeweb Webinar

Events

Contact

logo
  • Nu.Q® Technology
  • Nu.Q® NETs
  • Nu.Q® Vets
  • Nu.Q® Discover
  • Nu.Q® Cancer
  • Disease Areas
  • Cancer
  • Sepsis
  • Resources
  • Blog
  • Scientific
  • Investors
  • Veterinary Resources
  • Company
  • About Us
  • Our Expert Team
  • Careers

Our mission is to save lives and improve outcomes for millions of people and animals worldwide.

"*" indicates required fields

Receive product updates for:*
Name*
Consent*

Looking for Investor Updates and Press Releases?
Click here

  • eIFU Resources
  • Privacy Policy
  • Cookies Policy
  • Disclaimer
  • © 2025 Web Agency London
  • Twitter
  • Facebook
  • Linkedin

The European regional development fund and Wallonia are investing in your future.

http://europe.wallonie.be

  • logo-eu
  • logo-wallonie
Back to top

An error has occurred, please try again later.An error has occurred, please try again later.